← Back to Search

Nonsteroidal Anti-inflammatory Drug

Naproxen for Inflammation

Q: What medical conditions commonly warrant the prescription of Naproxen?

Naproxen is the most common medication utilized to treat nasal congestion. It can also be employed for cases of seasonal allergic rhinitis, autoimmune diseases, and muscle cramps.

Q: How many individuals are being monitored for the efficacy of this experiment?

Affirmative. Clinicaltrials.gov's records show this clinical study is actively recruiting, having been initially posted on February 9th 2022, and that approximately 50 patients are needed from 1 medical centre.

Q: To what extent has Naproxen been tested in past experiments?

At the moment, ten Naproxen trials are underway with four being in Stage 3. The majority of research for this drug is conducted in Philadelphia, <a href="https://www.withpower.com/clinical-trials/pennsylvania">Pennsylvania</a> yet there are eighteen locales participating overall.

Q: What criteria must an individual meet to qualify for participation in this trial?

50 individuals aged 45 to 60 with inflammation can join this medical study. The primary requirement for participation is that the patient must be a healthy adult between these age brackets.

Q: Does this research currently require new participants?

According to the latest information on clinicaltrials.gov, this experiment is still in search of participants. The trial was introduced to the public on February 9th 2022 and has since been revised as recently as May 19th 2022.

Q: Is the age of 55 and above eligible for enrolment in this research project?

The specified age range for this trial is 45 to 60 years old. In contrast, there are 29 trials specifically catering towards those younger than 18, and 272 that focus on individuals over 65.

Phase < 1

Waitlist Available

Led By Naomi I Eisenberger, Ph.D.

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (week 1 of study), post-intervention (week 4 of study)

Awards & highlights

Study Summary

This trial is investigating whether an anti-inflammatory medication can help improve the everyday lives of healthy individuals aged 45-60. Over the course of four weeks, participants will take either the medication or a placebo twice daily, and answer daily questions about their experiences. There are also two online study sessions, one before and one after the four weeks, where participants will fill out questionnaires and complete some computer tasks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (week 1 of study), post-intervention (week 4 of study)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (week 1 of study), post-intervention (week 4 of study)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (week 1 of study), post-intervention (week 4 of study) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Depression

Monetary reward task

Picture viewing task

+2 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: NaproxenActive Control1 Intervention

Group II: PlaceboPlacebo Group1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor

1,530 Previous Clinical Trials

10,278,132 Total Patients Enrolled

26 Trials studying Inflammation

2,788 Patients Enrolled for Inflammation

Naomi I Eisenberger, Ph.D.Principal InvestigatorUniversity of California, Los Angeles

1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What medical conditions commonly warrant the prescription of Naproxen?

"Naproxen is the most common medication utilized to treat nasal congestion. It can also be employed for cases of seasonal allergic rhinitis, autoimmune diseases, and muscle cramps."

Answered by AI

How many individuals are being monitored for the efficacy of this experiment?

"Affirmative. Clinicaltrials.gov's records show this clinical study is actively recruiting, having been initially posted on February 9th 2022, and that approximately 50 patients are needed from 1 medical centre."

Answered by AI

To what extent has Naproxen been tested in past experiments?

"At the moment, ten Naproxen trials are underway with four being in Stage 3. The majority of research for this drug is conducted in Philadelphia, Pennsylvania yet there are eighteen locales participating overall."

Answered by AI

What criteria must an individual meet to qualify for participation in this trial?

"50 individuals aged 45 to 60 with inflammation can join this medical study. The primary requirement for participation is that the patient must be a healthy adult between these age brackets."

Answered by AI

Does this research currently require new participants?

"According to the latest information on clinicaltrials.gov, this experiment is still in search of participants. The trial was introduced to the public on February 9th 2022 and has since been revised as recently as May 19th 2022."

Answered by AI

Is the age of 55 and above eligible for enrolment in this research project?

"The specified age range for this trial is 45 to 60 years old. In contrast, there are 29 trials specifically catering towards those younger than 18, and 272 that focus on individuals over 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Inflammation and Daily Life Study

Naomi Eisenberger 2022. "Inflammation and Daily Life Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03771612.